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Protein degradationFe65 is a highly conserved adaptor protein that interacts with several binding partners. Fe65 binds proteins to
mediate various cellular processes. But the interacting partner and the regulatory mechanisms controlled by
Fe65 are largely unknown. In this study, we found that Fe65 interacts with the C-terminus of Jagged1. Further-
more, Fe65 negatively regulates AP1-mediated Jagged1 intercellular domain transactivation in a Tip60-
independent manner. We found that Fe65 triggers the degradation of Jagged1, but not the Jagged1 intracellular
domain (JICD), through both proteasome and lysosome pathways. We also showed that Fe65 promotes recruit-
ment of the E3 ligase Neuralized-like 1 (Neurl1) to membrane-tethered Jagged1 and monoubiquitination of Jag-
ged1. These three proteins form a stable trimeric complex, thereby decreasing Jagged1 targeting by ubiquitin-
mediated degradation. Consequently, Jagged1 is a novel binding partner of Fe65, and Fe65may act as a novel ef-
fector of Jagged1 signaling.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Jagged1 is a single-pass transmembrane protein and aNotch1 recep-
tor ligand [1]. Jagged1 is overexpressed in breast and ovarian cancers
and promotes oncogenic functions, such asmetastasis and proliferation,
by enhancing the Notch signaling pathway [2–5]. Additionally, Jagged1
regulates hematopoiesis and inhibits vascular development in a Notch-
dependent manner, and Jagged1 knockout in mice models induces
embryonic lethality [6,7]. Jagged1 is sequentially cleaved by alpha-
and gamma-secretases, resulting in the release of the Jagged1
intracellular domain (JICD) [8]. Jagged1 also has a PDZ-domain binding
site at the C-terminus that is necessary for transforming activity, but has
no effect on Notch signaling [9]. The JICD positively regulates transcrip-
tional activity through the transcription factor Activator Protein 1 (AP1)
[8]. The Notch1 intracellular domain (Notch1-IC) is known to down-
regulate the transcriptional activity induced by AP1 [10].
Previously, we proposed that JICD induces the degradation of
Notch1-IC by enhancing ubiquitination of the Notch1-IC by promoting
interaction with the E3 ligase Fbw7 [11]. Because Jagged1 is
membrane-tethered, endocytosis and posttranslational modiﬁcationntracellular domain; Notch1-IC,
ces and Technology, Chonnam
00-757, Republic of Korea.
roteome@jnu.ac.kr (H.-S. Park).are important to stabilize Jagged1 protein level and activity [12]. The
E3 ligase Neuralized-like 1 (Neurl1) regulates protein stability of Jag-
ged1, and prevents Jagged1-mediated induction of the Notch signaling
pathway [13]. Neurl1 inhibits the expression of Notch target genes to
prevent the development of medulloblastoma [14]. However, to date,
the mechanisms regulating the Jagged1 pathway are largely unknown.
Fe65 is an evolutionarily conserved adaptor protein; it consists of a
WW domain and two consecutive phospho-tyrosine interaction do-
mains that are involved in protein–protein interactions [15]. Fe65 has
an important role in neuronal development and brain diseases, such
as Alzheimer's and Huntington's diseases [16–18]. In a previous study,
Fe65 was found to regulate APP processing and the Notch signaling
pathway by promoting the activity of gamma-secretase, thus enhancing
amyloid beta production [19,20]; ultimately, Fe65 inhibits Notch1
protein stability [21]. Fe65 binds to Notch1-IC, and inhibits binding to
transcription factor RBP-Jκ to suppress transactivation [21]. Moreover,
Fe65 accelerates the degradation of membrane-tethered Notch1 in the
cytoplasm. However, the study of Fe65 regulation of Jagged1 signaling
has not been thoroughly explored.
Here, we showed that Fe65 down-regulates the AP1-mediated
transactivation of Jagged1 or JICD in a Tip60-independent manner.
While Fe65 decreased Jagged1 protein stability in both proteasomal
and lysosomal degradation pathways, it did not reduce the JICD protein
level, but did suppress AP1-mediated JICD transactivation. In addition,
we demonstrated that JICD interacts with Fe65 in vitro and in vivo. We
showed that Neurl1 is involved in Fe65-mediated inhibition of Jagged1.
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monoubiquitination of Jagged1 thereby facilitated degradation of
Jagged1. This regulation is accomplished by the formation of a stable
trimeric complex between Jagged1, Neurl1, and Fe65. In sum, these
results suggest that Fe65 negatively regulates Jagged1 signaling.2. Materials and methods
2.1. Cell culture and transfection
Human embryonic kidney 293 (HEK293) and NIH3T3 mouse em-
bryonic ﬁbroblast cells were cultured at 37 °C in Dulbecco's Modiﬁed
Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum
(FBS) and 1% penicillin/streptomycin in a humidiﬁed incubator with
an atmosphere containing 5% CO2. For plasmid DNA transfection, the
cells were plated at a density of 50–60% conﬂuence, grown overnight,
and transfectedwith the appropriate expression vectors in the presence
of the indicated combinations of plasmids using either the calcium
phosphate method or Lipofectamine® 2000 reagent.2.2. Luciferase reporter assay
The luciferase assaywas conducted as previously described [21]. The
luciferase reporter plasmids were under the control of the AP1-
luciferase reporter plasmid, in either the absence or presence of combi-
nations of expression vectors along with beta-galactosidase, in 12-well
plates. After 48 h of transfection, the cells were lysed with chemilumi-
nescent lysis buffer, andwere analyzed using a Luminometer (Berthold)
for the luciferase assays. Luciferase activity in each sample was normal-
ized to beta-galactosidase activity, which had been premeasured in the
samples.2.3. Immunoblot analysis
Forty-eight hours after transfection, the cultured HEK293 cells were
harvested and lysed in RIPA buffer [50 mM Tris–HCl (pH 7.5), 150 mM
NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM
phenylmethylsulfonyl ﬂuoride (PMSF), 1 mM dithiothreitol (DTT), and
2 μg/ml each of leupeptin and aprotinin] for 10 min at 4 °C. The cell
lysateswere centrifuged for 20min at 12,000 g at 4 °C. The resultant sol-
uble fraction was boiled in Laemmli buffer and subjected to SDS-PAGE.
After gel electrophoresis, the separated proteins were transferred via
electroblotting onto polyvinylidene diﬂuoride (PVDF) membranes
(Millipore). The membranes were then blocked with Tris-buffered sa-
line solution (pH 7.4) containing 0.1% Tween 20 and 5% nonfat milk.
The blotted proteins were then probed with anti-Myc antibody
(9E10), anti-HA (12CA5) antibody, or anti-FLAG M2 antibody (Sigma),
Jagged1 C-terminal antibodies (Santa Cruz; sc-8303 and sc-6011),
anti-Fe65 antibody (upstate), and beta-actin antibody (Santa Cruz).
The blots were developed using enhanced chemiluminescence.2.4. Coimmunoprecipitation
Forty-eight hours after transfection, the cells were lysed for 10 min
in 1 ml of RIPA lysis buffer at room temperature. After 20 min of centri-
fugation at 12,000 g, the supernatants were subjected to immunopre-
cipitation with speciﬁc antibodies. After overnight incubation, protein
A-agarose beads were added, and the samples were incubated for 1 h
at 4 °C on a rotator. The beads were then washed three times with
ice-cold PBS, and boiling in protein sample buffer eluted any proteins
that remained bound to the beads. The samples were separated via
SDS-PAGE, and visualized by immunoblotting.2.5. In vitro binding assay
The recombinant GST-JICD protein was expressed in Escherichia coli
strain BL21, using the pGEX system, according to themanufacturer's in-
structions. The GST-JICD protein was then puriﬁed using glutathione-
agarose beads (Sigma), according to the manufacturer's instructions.
Equal amounts of GST or GST-JICD fusion proteins were incubated
with rotation with HEK293 cell lysates, which had previously been
transfected for 3 h with combinations of expression vectors at 4 °C.
The beads were then washed three times with ice-cold PBS, and boiled
with 20 μl of Laemmli sample buffer. The precipitateswere separated via
SDS-PAGE, and the pull-down proteins were detected via immunoblot-
ting with speciﬁc antibodies.
2.6. Protein stability assay
For the protein stability assay, the cells were seeded at a density of
50–60% conﬂuence and incubated overnight. Forty-two hours after
transfection, the cells were treated with 0.1 mM cycloheximide
(Sigma-Aldrich) for 0, 0.5, 1, 2, 4, or 6 h by adding it to the medium to
block the synthesis of new proteins. Cells were collected at each time
point and the total lysates were then lysed in RIPA or Laemmli sample
buffer. Endogenous Jagged1 protein levels were determined by immu-
noblotting with anti-Jagged1 antibody at a dilution of 1:1000.
2.7. Protein accumulation assay
For the protein accumulation assay, cells were seeded at a density of
50–60% conﬂuence and incubated overnight. Forty-two hours after
transfection, the cells were treated with proteasome inhibitor MG132
or ALLN or epoxomicin, or the lysosomal inhibitor chloroquine. In the
dosage assay, MG132 concentration was 1, 5, and 10 μM and cells
were treated for 6 h. The concentrations of the chemical inhibitors var-
ied, as follows: ALLN (25 μM), epoxomicin (100 μM), and chloroquine
(100 μM). Protein levels were determined by immunoblot analysis.
2.8. Ubiquitination assay
Forty-two hours after transfection, the cultured HEK293 cells were
treated with 5 μM MG132 for 6 h. Cells were collected and lysed for
10 min in 1 ml of RIPA lysis buffer at room temperature. After 20 min
of centrifugation at 12,000 g, Ni-NTA-agarose was added, and the sam-
ples were incubated for 3 h at 4 °C on a rotator. The beads were then
washed three times with ice-cold PBS; boiling in Laemmli buffer eluted
remaining proteins bound to the beads. The precipitateswere separated
via SDS-PAGE and visualized by immunoblottingwith anti-HAantibody.
2.9. Knockdown of Fe65
For the knockdown study, short hairpin (shRNA) oligonucleotides
were designed against the human Fe65 gene and subcloned into the
pGPU/GFP/Neo vector. The nucleotide sequences for the shRNA are as
follows: 5′-CUUAAUGCAUCUAUACUCUdTdT-3′ (upper strand) and 3′-
dTdTGAAUUACGUAGAUAUGAGA-5′ (lower strand). The shRNA of
Fe65 was transfected into HEK293 cells using Lipofectamine® 2000
according to the manufacturer's instructions.
3. Results
3.1. Fe65 suppresses AP1-mediated Jagged1 transactivation
To determine whether Jagged1 intracellular domain (JICD) stimu-
lates AP-1 mediated transactivation, we performed a reporter assay
using a luciferase reporter gene with the ADAM inhibitor or gamma
secretase inhibitor inHEK293 cells.We showed that theADAM inhibitor
TAPI-1 and gamma secretase inhibitor DAPT inhibits AP-1 mediated
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cessing of Jagged1 is important to activate the AP1-mediated
transactivation.
To investigate whether Fe65 regulates AP1-mediated Jagged1
transactivation, a reporter assay was conducted with HEK293 and
NIH3T3 cells using a luciferase reporter gene. JICD has been shown to
activate target genes through the transcription factor AP1 enhancer pro-
tein [8]. HEK293 cells were transfected with AP1-Luc along with either
Jagged1 or JICD. Like JICD, Jagged1 increases AP1-mediated transcrip-
tional activity (Fig. 1B–E).We showed that Fe65 suppresses AP1 activa-
tion by Jagged1 or JICD in HEK293 cells (Fig. 1B and C). Importantly,
these results occurred independently of cell type. Co-expression of
Fe65 attenuated Jagged1- and JICD-mediated AP1 transactivation in
NIH3T3 cells (Fig. 1D and E). These results indicate that Fe65 inhibits
AP1-mediated Jagged1 and JICD transactivation.
3.2. Tip60 does not affect Fe65-mediated inhibition of Jagged1 signaling
According to a previous study, Tip60 histone acetyltransferase is a
known binding partner of nuclear adaptor protein Fe65 and APP intra-
cellular domain (AICD). This Tip60–Fe65–AICD complex regulates
gene expression [22]. To determine whether Tip60 is involved in nega-
tively regulating AP1-mediated JICD transactivation by Fe65, we con-
ducted a reporter assay with HEK293 and NIH3T3 cells using a
luciferase reporter gene. TheHEK293 andNIH3T3 cells were transfected
with AP1-Luc along with either Jagged1, JICD, Tip60, or a Tip60 mutantFig. 1. Fe65 suppresses Jagged1 signaling: (A) HEK293 cells were transfectedwith AP1-Luc, Jagg
before harvesting, and luciferase activity was determined 48 h after transfection. (B) HEK293 c
Fe65 alongwith beta-galactosidase, as indicated. (C) HEK293 cells were transiently transfectedw
indicated. (D) NIH3T3 cells were transiently transfected with a luciferase reporter plasmid AP1
transiently transfected with a luciferase reporter plasmid AP1-Luc, JICD, and Fe65 along with
lysed, and the luciferase activitywasmeasured. The datawere normalized to beta-galactosidase(Tip60*) that cannot bind to Fe65. Both Tip60 and Tip60* produced no ef-
fect on Fe65-mediated inhibition of Jagged1 signaling (Fig. 2A and C).
These results indicate that Fe65 reduces the transcriptional activity of Jag-
ged1 in a Tip60-independent manner, independently of cell type (Fig. 2A
and C). We also tested the effect on Fe65-mediated inhibition of AP1-
mediated JICD transactivation by Tip60 or Tip60* (Fig. 2B and D). To de-
termine whether Tip60 regulates AP1-mediated Jagged and JICD
transactivation, we conducted a reporter assay with NIH3T3 cells using
a luciferase reporter gene. As shown in Fig. 2C and D, Tip60 and Tip60
mutant reduced Jagged1 and JICD transcriptional activity. These results
showed that not only Fe65 but also Tip60 reduces AP1-mediated
transactivation in a Tip60-independent and Fe65-independent manner,
respectively.
3.3. Fe65 facilitates Jagged1 degradation by both proteasomal and lysosomal
proteolysis
To assess the effect of Fe65 on Jagged1 and JICD protein stability,
HEK293 cells were subjected to western blot analysis. HEK293 cells
were co-transfected with HA-Jagged1 and Fe65-Myc in a dose-
dependentmanner.We determined that Fe65 reduced the Jagged1 pro-
tein level (Fig. 3A). To investigate the effect of Fe65 on JICD stability,
cells were co-transfected with GFP-JICD and Fe65-Myc in a dose-
dependent manner. We found that Fe65 exerted no effect on the stabil-
ity of JICD (Fig. 3B). To conﬁrm our observation that Fe65 decreased
Jagged1 expression, we designed an shRNA to stably knockdown Fe65.ed1with beta-galactosidase and treatedwith TAPI-1 (10 μM) for 4 h or DAPT (1 μM) for 6 h
ells were transiently transfected with a luciferase reporter plasmid AP1-Luc, Jagged1, and
ith a luciferase reporter plasmidAP1-Luc, JICD, and Fe65 alongwith beta-galactosidase, as
-Luc, Jagged1, and Fe65 along with beta-galactosidase, as indicated. (E) NIH3T3 cells were
beta-galactosidase, as indicated. (A–E) Forty-eight hours after transfection, the cells were
activity. The results are expressed as themean±SD from three independent experiments.
Fig. 2. Fe65 inhibits transactivation of Jagged1 in a Tip60-independent manner: (A) HEK293 cells were transiently transfected with a luciferase reporter plasmid AP1-Luc, Jagged1, Fe65,
Tip60, and Tip60* mutant along with beta-galactosidase, as indicated. (B) HEK293 cells were transiently transfected with a luciferase reporter plasmid AP1-Luc, JICD, Fe65, Tip60, and
Tip60* mutant along with beta-galactosidase, as indicated. (C) NIH3T3 cells were transiently transfectedwith a luciferase reporter plasmid AP1-Luc, Jagged1, Fe65, Tip60, and Tip60*mu-
tant alongwith beta-galactosidase, as indicated. (D) NIH3T3 cells were transiently transfectedwith a luciferase reporter plasmid AP1-Luc, JICD, Fe65, Tip60, and Tip60*mutant alongwith
beta-galactosidase as indicated. (A–D) Forty-eight hours after transfection, the cells were lysed and the luciferase activity was measured. The data were normalized to beta-galactosidase
activity. The results are expressed as the mean ± SD from three independent experiments.
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dependent manner and Fe65 protein was detected via western blot
analysis. We conﬁrmed that shFe65 efﬁciently inhibits the expression
of Fe65 (Fig. 3C). HEK293 cells were co-transfected with HA-Jagged1,
Fe65-Myc, and shFe65; Jagged1 level was reduced by Fe65, and Fe65-
mediated degradation of Jagged1 was restored by Fe65 knockdown
(Fig. 3D). To conﬁrm the regulation of Fe65 on endogenous Jagged1
level, HEK293 cells were transfected with shFe65 in a dose-dependent
manner. We determined that the endogenous Jagged1 protein level in-
creased with Fe65 knockdown (Fig. 3E).
To evaluate whether Jagged1 degradation is mediated by the
proteasomal pathway, the proteasome inhibitor MG132 was employed
to treat Jagged1-expressing and Fe65-expressing cells. HEK293 cells
were transiently transfected with HA-Jagged1 and Fe65-Myc. The cells
were treated with MG132 (1, 5, 10 μM) for 6 h before harvesting.
Jagged1 protein level was reduced in the presence of Fe65, but was sig-
niﬁcantly restored by treatment with MG132 in a concentration-
dependent manner (Fig. 3F). Using HEK293 cells co-transfected with
HA-Jagged1 and Fe65-Myc, we conﬁrmed that Fe65-mediated decrease
in Jagged1 level is through degradation via the proteasomal pathway.
The cells were then treated with proteasome inhibitors MG132
(5 μM), ALLN (25 μM), and epoxomicin (100 μM) for 6 h beforeharvesting. Similar to MG132, Jagged1 also increased with ALLN and
epoxomicin treatment (Fig. 3G). MG132 is a widely used proteasome
inhibitor that blocks proteasomal degradation and, to a lesser extent, in-
terrupts lysosomal proteases [23]. Many transmembrane proteins are
sorted to the inner membranes of endosomes and lysosome after
ubiquitination. The integral membrane proteins are then degraded by
proteolytic enzymes in the lysosome [24]. To assess whether Jagged1
protein is degraded by lysosomal proteolysis, Jagged1-expressing and
Fe65-expressing cells were treated with the lysosomal inhibitor chloro-
quine. We found that Fe65 also induces lysosomal proteolysis in the
degradation of Jagged1 (Fig. 3H). Taken together, our results indicate
that Fe65 negatively regulates Jagged1 protein stability in both the
proteasomal and lysosomal degradation pathways.
3.4. Fe65 interacts directly with Jagged1 and JICD in intact cells
To determine whether Fe65 physically interacts with Jagged1,
HEK293 cells were subjected to co-immunoprecipitation. The cells
were transiently transfected with HA-Jagged1 and Fe65-Myc. The cell
lysateswere subjected to immunoprecipitationwith anti-Myc antibody.
The immunoprecipitates were immunoblotted with anti-HA antibody.
We found that Fe65 directly binds to Jagged1 (Fig. 4A). HEK293 cells
Fig. 3. Fe65 destabilizes Jagged1, but not JICD, through both proteasomal and lysosomal degradation pathways: (A) HEK293 cells were transiently transfectedwith HA-Jagged1 and Fe65-
Myc. (B) HEK293 cells were transiently transfected with GFP-JICD and Fe65-Myc. (C) HEK293 cells were transiently transfected with Fe65-Myc and shFe65. (D) HEK293 cells were tran-
siently transfected with HA-Jagged1, Fe65-Myc, and shFe65. (E) HEK293 cells were transiently transfected with shFe65 in a dose-dependent manner. (F) HEK293 cells were transiently
transfected with HA-Jagged1 and Fe65-Myc. The cells were treated with MG132 at the indicated concentration for 6 h before harvesting. (G) HEK293 cells were transiently transfected
with HA-Jagged1 and Fe65-Myc. The cells were treated with MG132 (5 μM), ALLN (25 μM), or epoxomicin (100 μM) for 6 h before harvesting. (H) HEK293 cells were transiently
transfected with HA-Jagged1 and Fe65-Myc. The cells were treated with chloroquine at the indicated concentration for 6 h before harvesting. (A–H) Forty-eight hours after transfection,
the cell lysates were subjected to immunoblot analysis with the indicated antibodies.
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tween Jagged1 and Fe65. The cell lysates were immunoprecipitated
with anti-Fe65 or IgG antibody, and the immunoprecipitates were
immunoblotted with anti-Jagged1 antibody. These results conﬁrmed
that endogenous Fe65 physically interacts with endogenous Jagged1
(Fig. 4B). To assess the physical binding between JICD and Fe65,we con-
ducted an in vitro binding assay. Recombinant GST or GST-JICD proteins
were immobilized onto GSH-agarose. HEK293 cells were transiently
transfected with Fe65-Myc. The cell lysates were subjected to GSTpull-down experiments with immobilized GST or GST-JICD. Proteins
bound to GST or GST-JICD were analyzed via immunoblotting with an
anti-Myc antibody. We found that Fe65 directly interacts with JICD
(Fig. 4C). The cells were then transiently transfected with GFP-JICD
and Fe65-Myc to conﬁrm the interaction between JICD and Fe65. The
cell lysates were subjected to immunoprecipitation with anti-Myc anti-
body. The immunoprecipitates were immunoblotted with anti-GFP an-
tibody. These data suggest that Fe65 directly binds to JICD (Fig. 4D). To
conﬁrm the endogenous interaction between JICD and Fe65, we
Fig. 4. Fe65 physically interacts with Jagged1 and JICD: (A) HEK293 cells were transiently transfectedwith HA-Jagged1 and Fe65-Myc. Forty-eight hours after transfection, the cell lysates
were subjected to immunoprecipitationwith anti-Myc antibody. The immunoprecipitateswere immunoblottedwith anti-HA antibody. (B) HEK293 cellswere transiently transfectedwith
shControl and shFe65. Forty-eight hours after transfection, the cell lysates were immunoprecipitated with anti-Fe65 or IgG antibody, and the immunoprecipitates were immunoblotted
with anti-Jagged1 antibody. (C) RecombinantGST orGST-JICD proteinswere immobilized onto GSH-agarose. HEK293 cellswere transiently transfectedwith Fe65-Myc. After 48 h of trans-
fection, the cell lysates were subjected to GST pull-down experiments with immobilized GST or GST-JICD. Proteins bound to GST or GST-JICDwere analyzed via immunoblottingwith anti-
Myc antibody. The input represents 1% of the cell lysate prior to in vitro binding assay. (D) HEK293 cells were transiently transfectedwith GFP-JICD and Fe65-Myc. Forty-eight hours after
transfection, the cell lysates were subjected to immunoprecipitation with anti-Myc antibody, and the immunoprecipitates were immunoblotted with anti-GFP antibody. (E) HEK293 cell
lysates were immunoprecipitated with anti-Fe65 or IgG antibody, and the immunoprecipitates were immunoblotted with anti-Jagged1 C-terminal antibody. Cell lysates were also sub-
jected to immunoblot analysis with the indicated antibodies.
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lysates were immunoprecipitated with anti-Fe65 or IgG antibody, and
the immunoprecipitates were immunoblotted with anti-Jagged1
C-terminal antibody. These results conﬁrmed that endogenous Fe65
physically interacts with endogenous JICD (Fig. 4E).
3.5. Fe65 negatively regulates Jagged1 signaling via the E3 ligase Neurl1
We discovered that Fe65 degrades Jagged1 protein through
proteasomal and lysosomal proteolysis. To conﬁrm whether the
proteasomal pathway is involved in Fe65-mediated regulation of Jag-
ged1, we performed a reporter assay and western blot analysis using
the proteasomal inhibitor, MG132. HEK293 cells were transfected
with AP1-Luc and Jagged1 and treated with MG132 for 6 h before har-
vesting, and luciferase activity was determined 48 h after transfection.
We found that MG132 restores the Fe65-mediated down-regulation of
transcriptional activation of Jagged1 (Fig. 5A). To conﬁrm whether the
lysosome pathway is involved in Fe65-mediated regulation of Jagged1,
we performed a reporter assay using the lysosomal inhibitor, chloro-
quine. HEK293 cells were transfected with AP1-Luc and Jagged1 and
treated with chloroquine for 6 h before harvesting, and luciferase activ-
ity was determined 48 h after transfection. We found that chloroquine
restores the Fe65-mediated down-regulation of transcriptional activa-
tion of Jagged1 (Fig. 5B) but the increased population of Fe65suppresses the chloroquine-mediated up-regulation of transcriptional
activation of Jagged1 (Fig. 5C). As a result, we demonstrated that Fe65
is crucial for the regulation of transcriptional activation of Jagged1.
Neurl1 regulates Jagged1 signaling activity by directly enhancing its
ubiquitination and subsequent turnover [13]. To determine whether
Neurl1 is involved in negatively regulating Jagged1 target gene tran-
scription activity by Fe65, a reporter assay was conducted with
HEK293 cells. We introduced a dominant negative Neurl1 mutant
(Neurl1 Rm) in which two highly conserved RING domain cysteine
residues, Cys521 and Cys524, have been changed to serines [13].
Fe65-mediated inhibition of Jagged1 was restored by dominant nega-
tive Neurl1 Rm (Fig. 5D), suggesting that Neurl1 has a critical role in
Fe65-mediated Jagged1 down-regulation. HEK293 cells were
transfected with shControl and shFe65 and then treated with the pro-
teasome inhibitor MG132. We found that endogenous Jagged1 protein
level is enhanced in the absence of Fe65 and signiﬁcantly restored by
MG132 treatment (Fig. 5E). To assess whether Fe65 negatively regu-
lates the transcriptional activity of JICD, HEK293 cells were transfected
with AP1-Luc and JICD. The cells were treated with MG132 for 6 h,
lysed, and subjected to a reporter assay. Consistent with previous
data, the transcriptional activation of JICD was inhibited by Fe65, but
was not restored by MG132 (Fig. 5F). These results suggest that Fe65
down-regulates JICD transcriptional activity without degradation of
JICD.
Fig. 5. The E3 ligase Neurl1 is involved in Fe65-mediated negative regulation of Jagged1: (A)HEK293 cellswere transiently transfectedwith a luciferase reporter plasmidAP1-Luc, Jagged1,
and Fe65 along with beta-galactosidase, as indicated. The cells were treated with MG132 for 6 h before harvesting. (B, C) HEK293 cells were transiently transfected with a luciferase re-
porter plasmid AP1-Luc, Jagged1, and Fe65 alongwith beta-galactosidase, as indicated. The cellswere treatedwith chloroquine for 6 h before harvesting. (D)HEK293 cellswere transiently
transfectedwith a luciferase reporter plasmid AP1-Luc, Jagged1, Fe65, andNeurl1 Rm alongwith beta-galactosidase, as indicated. (A–D)After 48 h transfection, the cellswere lysed and the
luciferase activity was determined. The data were normalized to β-galactosidase activity. The results are expressed as the mean ± SD from three independent experiments. (E) HEK293
cells were transiently transfected with shControl and shFe65. Forty-eight hours after transfection, cells were treated with MG132 for 6 h before harvesting and then subjected to immu-
noblot analysis with the indicated antibodies. (F) HEK293 cells were transiently transfected with a luciferase reporter plasmid AP1-Luc, JICD, and Fe65 along with beta-galactosidase, as
indicated. The cells were treated with MG132 for 6 h before harvesting and the luciferase activity was measured.
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complex with Jagged1 and the E3 ligase Neurl1
To determine whether Fe65 regulates Jagged1 stability, we exam-
ined ectopically expressed or endogenous Jagged1 protein levels by
treatment with cycloheximide for up to 6 h. HA-Jagged1 and Fe65-
Myc were expressed in HEK293 cells and Jagged1 levels were evaluated
after various periods of cycloheximide treatment. After cycloheximidetreatment, the protein stability of Jagged1 decreased gradually and ap-
proximately half of the protein was degraded after 5 h. Fe65, however,
markedly accelerated the degradation of Jagged1 and approximately
half of the proteinwasdegraded after 2 h (Fig. 6A). Next,we determined
the protein stability of endogenous Jagged1 after cycloheximide treat-
ment with or without shFe65 in HEK293 cells. After cycloheximide
treatment, the endogenous Jagged1 level dropped gradually and ap-
proximately half of the protein was degraded after 5 h without Fe65.
Fig. 6. Fe65 suppresses Jagged1 by increasing recruitment of E3 ligase Neurl1 and forming a stable tertiary complex: (A) HEK293 cells were transiently transfected with shControl or
shFe65. (B) HEK293 cells were transiently transfected with HA-Jagged1 alone or HA-Jagged1 with Fe65-Myc. A–B, The cell lysates were treated with cycloheximide in a time-dependent
manner as indicated before harvesting, and then subjected to immunoblot analysis with the indicated antibodies. (C) HEK293 cells were transiently transfected with HA-Jagged1, His-ub,
and Fe65-Myc. Forty-eight hours after transfection, the cell lysates were added with Nickel-agarose and immunoblot analysis with anti-HA antibody. (D) HEK293 cells were transiently
transfectedwith HA-Jagged1, His-ub, Fe65-Myc, Neurl1-Flag, and NeurlRm-Flag. Forty-eight hours after transfection, the cells were treatedwithMG132 for 6 h before harvesting and lysis.
The cell lysates were added with Nickel-agarose and immunoblot analysis with anti-HA antibody. (E) HEK293 cells were transiently transfectedwith HA-Jagged1, Neurl1-Flag, and Fe65-
Myc. Forty-eight hours after transfection, the cell lysateswere subjected to immunoprecipitationwith anti-Flag antibody and immunoblot analysiswith anti-HA antibody. (F)HEK293 cells
were transiently transfectedwith HA-Jagged1, Neurl1-Flag, and Fe65-Myc. Forty-eight hours after transfection, the cells were treated withMG132 for 6 h before harvesting and lysis. The
cell lysates were subjected to immunoprecipitation with anti-Flag antibody and immunoblot analysis with the indicated antibodies.
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ment and approximately half of the protein was degraded after 1 h in
the presence of Fe65 (Fig. 6B). The ubiquitin-mediated degradation
pathway is the major protein degradation system to regulate the pro-
tein homeostasis and cell signal transduction. Jagged1 is also regulated
by the E3 ligase Neuralized-like1 (Neurl1), which induces the
monoubiquitination of membrane-tethered Jagged1 in the C-terminal
region. This ubiquitination promotes the endocytosis and degradation
of Jagged1 by the lysosomal degradation pathway [13]. To examine
the effect of Fe65 on the ubiquitination of Jagged1, we conducted an
ubiquitination assay. HEK293 cells were co-transfected with HA-
Jagged1, His-ub, and Fe65-Myc. The cell lysates were pulled down
with Nickel-agarose and were subjected to immunoblot analysis with
anti-HA antibody. We determined that Fe65 increased the
monoubiquitination of Jagged1 (Fig. 6C). To assess whether Neurl1 is
involved in Fe65-mediated ubiquitination of Jagged1, we introducedFig. 7.A schematicmodel depicting a possible role of Fe65 in Jagged1 signaling: Fe65 binds JICD
promotes the recruitment of the E3 ligaseNeurl1 tomembrane-tethered Jagged1, inducingmon
pathways. Fe65 binds Jagged1 and Neurl1 by forming a trimeric complex between these proteeither Flag-Neurl1 or dominant negative Neurl1 Rm. Fe65-induced
ubiquitination of Jagged1 was mediated by Neurl1 but not by domi-
nant negative Neurl1 Rm (Fig. 6D). We determined that the RING do-
main of Neurl1 is important to the Fe65-induced ubiquitination of
Jagged1. Therefore, we also attempted to investigate whether Fe65
regulates the physical interaction between Jagged1 and Neurl1, or
forms a trimeric complex. HA-Jagged1, Neurl1-Flag and Fe65-Myc
were expressed in HEK293 cells, and the cell lysates were
immunoprecipitated with anti-Flag antibody, and the immunopre-
cipitates were immunoblotted with anti-HA antibody or anti-Myc
antibody respectively. We found that Fe65 positively regulates the
binding of Neurl1 to Jagged1 (Fig. 6E), and facilitates the interaction
of Jagged1 and Neurl1 via the formation of a trimeric complex
(Fig. 6F). These results suggest that Fe65 increases the association
between Jagged1 and Neurl1, thus inducing the ubiquitin-mediated
degradation of Jagged1.and inhibits the transactivation induced by JICD through the transcription factor AP1. Fe65
oubiquitination of Jagged1, accelerating Jagged1 degradation via proteasome and lysosome
ins.
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Here, we report that Jagged1 is a novel binding partner of Fe65, and
Fe65 suppresses Jagged1 signaling. We showed that Fe65 inhibits AP1-
mediated Jagged1 transactivation. We also showed that Fe65 regulates
Jagged1, a ligand of Notch1 signaling with a regulator as an enhancer
of the interaction of Jagged1 and Neurl1 with increasing degradation
of Jagged1. We demonstrated that Fe65 down-regulates AP1-mediated
JICD transactivation by binding to JICD directly; Fe65, however, does
not affect the protein stability of JICD (Fig. 7). Jagged1 is a single pass
transmembrane protein and is successively processed by alpha- and
gamma-secretases to produce signaling fragments [1,8]. The signaling
fragment, JICD, is trans-located to the nucleus to regulate target genes
[9]. In addition to PDZ-dependent signaling, JICD also regulates tran-
scriptional activity through the transcription factor AP1 [8]. Jagged1
processing is similar to that of amyloid precursor protein (APP) and
Notch1, in that Jagged1 is subjected to an S2 cleavage like Notch pro-
cessing and alpha-secretase-like cleavage (APP processing) that com-
monly use ADAM17 and TACE-like activity [8].
Fe65 is known to regulate membrane-spanning proteins, such as
APP and Notch1 [21,25]. Fe65 protects amyloid beta from proteolytic
degradation, and promotes transactivation [19,20]. Fe65 suppresses
transcriptional activation of Notch1-IC by disrupting the interaction be-
tween Notch1-IC and RBP-Jκ [21]. In addition, Fe65 reduces the protein
level of membrane-tethered Notch1. Fe65 forms a complex with the in-
tracellular domain of beta-amyloid precursor protein (AICD) and Tip60
histone acetyltransferase [22,26]. We explored whether Fe65 may sim-
ilarly regulate Jagged1 signaling. We used a mutant Tip60 that cannot
interact with Fe65 to block the AICD–Fe65–Tip60 tertiary complex.
We found that Fe65 inhibits AP1-mediated JICD transactivation in a
Tip60-independentmanner.We further investigatedwhether Fe65 reg-
ulates the protein stability of Jagged1 or JICD and found that Jagged1 is
degraded by both proteasomal and lysosomal proteolysis, whereas JICD
is stable with Fe65 overexpression. Despite this, Fe65 does suppress
JICD transactivation. To explore this further, we examined whether
Fe65 directly binds to JICD to suppress transactivation and, by
conducting an in vitro pull-down assay and co-immunoprecipitation
in vivo, found that Fe65 directly interacts with JICD. The interaction be-
tween Fe65 and JICD inhibits JICD-induced signaling. Further, we dem-
onstrated that Fe65 binds to membrane-tethered Jagged1.
Jagged1 is ubiquitinated, and degraded by the E3 ligase Neurl1 [12,
13]. Neurl1 is targeted to the membrane after it is posttranslationally
modiﬁed by N-myristoylation [13]. Neurl1 induces monoubiquitination
of Jagged1 speciﬁcally,whereas it has no effect on otherNotch ligands in
mammals.Monoubiquitination is regarded as a signal for endocytosis of
a transmembrane protein [27]. In this study, we found that Fe65 acti-
vates the recruitment of Neurl1 to membrane-tethered Jagged1. Fur-
thermore, we demonstrated that Fe65 increases monoubiquitination
of Jagged1 by Neurl1; the Neurl1 RING domain is necessary for E3 ubiq-
uitin ligase activity. ANeurlmutant, substituted at twohighly conserved
residues, C521S and C524S, was used to examine whether Fe65 regu-
lates the ubiquitination of Jagged1 through Neurl1. We conﬁrmed that
Neurl1 is involved in Fe65-mediated ubiquitination of Jagged1 using a
dominant negative Neurl1 mutant (Neurl1 Rm) with a nonfunctional
RING domain. This experiment showed that Fe65-induced ubiquitination
is regulated in a Neurl1-dependent manner. Consequently, Fe65
promotes the recruitment of Neurl1 to Jagged1, and stimulates
ubiquitination and degradation of Jagged1. In addition to this, we
found that Fe65 forms a trimeric complex with Jagged1 and Neurl1,
and increases ubiquitin-dependent proteolysis of Jagged1 (Fig. 7). In a
previous study, we demonstrated that Fe65 negatively regulates
canonical Notch1 signaling by disrupting Notch1-IC and transcription
factor RBP-Jκ binding, and suppressing transactivation induced by
Notch1-IC [21]. Moreover, we showed that Fe65 reduces membrane-
tethered Notch1 levels. Furthermore, Fe65 forms a trimeric complex
between membrane-bound Notch1 and the E3 ubiquitin ligase Itch[21]. Subsequently, in this study, we have now demonstrated a pivotal
role for Fe65 in the regulation of the Notch1 receptor. We have also
shown that Fe65 also regulates Jagged1, a Notch ligand. Our results
suggest that Fe65 is able to control both the Notch receptor and ligand
in a bi-directional manner.
In conclusion, Jagged1 is a novel binding partner of Fe65, and Fe65
acts as negative regulator in Jagged1 signaling by triggering the degra-
dation of membrane-tethered Jagged1. Fe65 suppresses AP1-mediated
JICD transactivation via direct binding to JICD,while Fe65does not affect
protein stability of JICD. Additionally, Fe65 recruits Neurl1 to Jagged1,
which is then subjected to monoubiquitination, endocytosis, and ulti-
mately degradation. Although Jagged1 signaling is not well deﬁned,
the results of these studies provide some promise for research on Jag-
ged1 signal transduction.
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